Close Menu
  • Home
  • Holiday Loops
  • Advertise with Us
  • About & Contact
  • Good News
  • Get Involved
  • Podcast
  • Support Us

Subscribe to Updates

Get the latest good news and other great things from STN.

What's Hot

Boy Given 1% Chance of Survival Walks 5k for Hospital That Saved Him–After Air Rifle Shot to the Head as Baby

June 30, 2025

Taking a Summer Break – Thank You for All the Support!

June 30, 2025

Check Out the Events this Weekend, June 27-July 7 Weekends in the Mahoning Valley

June 27, 2025
Facebook Instagram LinkedIn YouTube
Facebook Instagram LinkedIn YouTube
Spanning the Need: Good News, Inspiring, the Uninspired.
Subscribe Login
  • About
    • About & Contact
    • Advertise with Us
    • Legal
    • Vote
  • Holiday Loops
  • Podcast
  • Good News
  • Get Involved
  • Events
  • Support Us
Spanning the Need: Good News, Inspiring, the Uninspired.
Home » Good News » Selonterra Awarded US $2,500,000 Grant from The Michael J. Fox Foundation for Parkinson’s Research
News

Selonterra Awarded US $2,500,000 Grant from The Michael J. Fox Foundation for Parkinson’s Research

STN StaffBy STN StaffMay 25, 2023Updated:May 25, 2023No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

Selonterra, Inc, a biotechnology company developing transformative therapies for neurodegenerative disorders announces a grant award of US $2,500,000 from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

Selonterra focuses on neurodegenerative disorders with strong genetic links. Selonterra’s team discovered that DNA changes associated with key genetic determinants in Parkinson’s and Alzheimer’s disease control the expression of genes in their chromosomal vicinity. The latter genes are the true mediators of these diseases and offer novel, unexploited targets for therapy development. Shared common pathways in these neurodegenerative disorders allow us to develop small molecules with the potential to profoundly change Parkinson’s and Alzheimer’s disease therapies.

POTW: Kristin Fox, Northeast Ohio Impact Academy-Campbell City Schools(Opens in a new browser tab)

Funding from The Michael J. Fox Foundation enables Selonterra to link novel targets to clinical dysfunctions in Parkinson’s disease and to optimize our small molecules towards clinical candidates.

“We are immensely grateful to receive this funding from The Michael J. Fox Foundation to support these completely unexploited approaches with the potential of a meaningful impact on patients with Parkinson’s disease,” said Roman Urfer, PhD, Founder and CEO of Selonterra.

“The contribution of genetics to Parkinson’s disease is undisputed,” said Anne Urfer-Buchwalder, PhD, Founder and President of Selonterra. “In contrast to an involvement of the proteins encoded by these genetic variants, our focus on the DNA sequence and the genes that these DNA variants control offers fundamentally different therapeutic opportunities.”

POTW, Collins Michaels, Campbell Memorial Red Devils(Opens in a new browser tab)

“MJFF greatly values research that takes fresh looks at the biological underpinnings of Parkinson’s disease and leverages that insight for new treatment ideas. We are proud to support the work of researchers like the team at Selonterra as they investigate new ways to fulfill the unmet needs of people with Parkinson’s,” said Brian Fiske, PhD, Co-Chief Scientific Officer, MJFF.

Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous ArticleCan you go Plastic Free for One Day?
Next Article Hyundai Launches Third-Annual Women in STEM Scholarship of $10,000 Each
STN Staff

    Related Posts

    By STNJune 30, 2025 News

    Boy Given 1% Chance of Survival Walks 5k for Hospital That Saved Him–After Air Rifle Shot to the Head as Baby

    By STNJune 30, 2025 Community & Activism

    Taking a Summer Break – Thank You for All the Support!

    By STN StaffJune 17, 2025 Business & Finance

    Honoring Athena Nominees for 2025: Vanessa Jones-Washington, Vasilia Vamvakis and Vicki Vicars

    By STN StaffJune 16, 2025 News

    Hero Dog Wakes Up Owners After Sensing Fire Across Street: ‘Bark was Unlike’ Any Heard Before

    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    Subscribe to Updates

    Get the latest good news and other great things from STN.

    Demo
    Recent Posts
    • Boy Given 1% Chance of Survival Walks 5k for Hospital That Saved Him–After Air Rifle Shot to the Head as Baby June 30, 2025
    • Taking a Summer Break – Thank You for All the Support! June 30, 2025
    • Check Out the Events this Weekend, June 27-July 7 Weekends in the Mahoning Valley June 27, 2025
    • Honoring Athena Nominees for 2025: Paula Baco, Rachael Dobson and Patricia Summers June 26, 2025
    • Man Is Overwhelmed with Emotion Trying Color Blind Glasses for First Time–‘My God. This is Amazing’ (WATCH) June 25, 2025
    Follow Us
    • Facebook
    • LinkedIn
    • Instagram
    • YouTube
    Don't Miss
    News

    Boy Given 1% Chance of Survival Walks 5k for Hospital That Saved Him–After Air Rifle Shot to the Head as Baby

    By STNJune 30, 202502 Mins Read

    A boy who nearly died after he was shot in the head as a baby…

    Taking a Summer Break – Thank You for All the Support!

    June 30, 2025

    Check Out the Events this Weekend, June 27-July 7 Weekends in the Mahoning Valley

    June 27, 2025

    Honoring Athena Nominees for 2025: Paula Baco, Rachael Dobson and Patricia Summers

    June 26, 2025

    Man Is Overwhelmed with Emotion Trying Color Blind Glasses for First Time–‘My God. This is Amazing’ (WATCH)

    June 25, 2025
    Newsletter

    Facebook Instagram LinkedIn YouTube
    • Home
    • About & Contact
    • Advertise with Us
    • Good News
    • Events
    © Copyright 2025. STN | Spanning the Need. All Rights Reserved. Privacy Policy & Legal Disclaimer. Website design by Gallagher Website Design

    Type above and press Enter to search. Press Esc to cancel.

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?